Search

Displaying results 1921 - 1930 of 10000 in total
  1. Indication

    Diabetic Peripheral Neuropathy (DPN)

    go.drugbank.com/conditions/DBCOND0049986
    Drugs: Mepivacaine
    Synonyms: Neuropathy co-occurrent and due to diabetes mellitus, Peripheral neuropathy co-occurrent and due to diabetes mellitus
  2. Indication

    Urinary Tract Disorders

    go.drugbank.com/conditions/DBCOND0146598
    Drugs: Ciclonium bromide
    Synonyms: Renal and urinary disorders, Unspecified disorder of urethra and urinary tract
  3. Drug

    ET140203

    go.drugbank.com/drugs/DB17196
    Investigational

    Synonyms: an autologous T-cell immunotherapy (ET140203)
  4. Drug

    Lumefantrine

    go.drugbank.com/drugs/DB06708
    ApprovedInvestigational

    </i> and may be used to treat infections caused by <i>P. falciparum</i> and unidentified <i>Plasmodium</i> species, including infections acquired in chloroquine-resistant areas. … Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with artemether for improved efficacy.

    Mixtures: COARTEM® TABLETAS DISPERSABLES 20/120MGCategories: artemether and lumefantrine, Antiparasitic Products, Insecticides and Repellents
  5. Target

    Adiponectin receptor

    go.drugbank.com/bio_entities/BE0010287
    TargetHumans

    Required for normal glucose and fat homeostasis and for maintaining a normal body weight. … Receptor for ADIPOQ, an essential hormone secreted by adipocytes that regulates glucose and lipid metabolism (PubMed:12802337, PubMed:25855295). Required for normal body fat and glucose homeostasis.

    Synonyms: Progestin and adipoQ receptor family member 1, Progestin and adipoQ receptor family member I
  6. Drug

    Depemokimab

    go.drugbank.com/drugs/DB18846
    ApprovedInvestigational

    [A275338] Approved by the FDA on December 16, 2025, depemokimab is indicated as an add-on maintenance treatment for severe asthma characterized by an eosinophilic phenotype in adult and paediatric patients … aged 12 years and older.

    Categories: Amino Acids, Peptides, and Proteins
  7. Indication

    Opioid Dependence

    go.drugbank.com/conditions/DBCOND0030983
    Drugs: Buprenorphine · Lactose · Levomethadone · Naloxone · Naltrexone
    Synonyms: [X]Mental and behavioral disorders due to use of opioids: dependence syndrome, [X]Mental and behavioural disorders due to use of opioids: dependence syndrome
  8. Drug

    Imipenem

    go.drugbank.com/drugs/DB01598
    ApprovedInvestigational

    [A15389] Imipenem is commonly used in combination with [cilastatin] and is now available in a triple-drug product with cilastatin and [relebactam] which was recently approved by the FDA. … Imipenem was first approved by the FDA in November 1985 as the combination product Primaxin marketed by Merck & Co.[L7628]

    Mixtures: Hovid Imipenem + Cilastatin for Injection 250mg/250mg, Imipenem and CilastatinCategories: imipenem and cilastatin, imipenem, cilastatin and relebactam
  9. Drug

    Revakinagene taroretcel

    go.drugbank.com/drugs/DB05344
    ApprovedInvestigational

    Revakinagene taroretcel is an intraocular implant that contains human cells that have been genetically modified to secrete ciliary neurotrophic factor (CNTF). … [L52540] It has also been investigated in glaucoma,[A265115] retinitis pigmentosa (RP), and age-related macular degeneration.[A265125]

    Categories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and ProteinsSynonyms: An allogeneic human adult retinal pigment epithelial (RPE) cell line stably transfected with a plasmid
  10. Drug

    Bictegravir

    go.drugbank.com/drugs/DB11799
    ApprovedInvestigational

    [L64114] It is not administered alone; it is available in fixed-dose combination tablets, with [tenofovir alafenamide] and [emtricitabine], and with [lenacapavir].[L50522, L64114]

    Mixtures: BIKTARVY FILM-COATED TABLETS 50MG/200MG/25MGCategories: emtricitabine, tenofovir alafenamide and bictegravir